158 related articles for article (PubMed ID: 6264421)
1. Renal allograft function and cytomegaly.
Jirka J; Horcicková M; Reneltová I; Rossmann P; Seeman J; Holá V; Kocandrle V
Proc Eur Dial Transplant Assoc; 1980; 17():407-12. PubMed ID: 6264421
[TBL] [Abstract][Full Text] [Related]
2. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
3. [Relation between cytomegalovirus infection and the so-called intolerance to azathioprine in renal transplantation].
Ancona G; Dean P; Muolo A; Galvani E; Zanuso C; Gulino S; Confortini P
Minerva Chir; 1980 May; 35(10):731-4. PubMed ID: 6256686
[TBL] [Abstract][Full Text] [Related]
4. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection and kidney graft survival.
Spencer ES; Fjeldborg O; Andersen HK
Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
[TBL] [Abstract][Full Text] [Related]
6. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
7. Impact of donor age on renal allograft function and survival.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
[TBL] [Abstract][Full Text] [Related]
8. The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation.
Betts RF
Birth Defects Orig Artic Ser; 1984; 20(1):87-99. PubMed ID: 6329375
[No Abstract] [Full Text] [Related]
9. Pediatric renal transplantation: single center experience.
Mir S; Erdoğan H; Serdaroğlu E; Kabasakal C; Hoşcoşkun C
Pediatr Transplant; 2005 Feb; 9(1):56-61. PubMed ID: 15667613
[TBL] [Abstract][Full Text] [Related]
10. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
11. Kidney allograft outcome in simultaneous pancreas-kidney transplantation.
Nakache R; Weinbroum A; Merhav H; Kaplan E; Kariv Y; Khoury W; Gutman M; Klausner JM
Isr Med Assoc J; 2000 Jul; 2(7):517-9. PubMed ID: 10979325
[TBL] [Abstract][Full Text] [Related]
12. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
13. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
14. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
[No Abstract] [Full Text] [Related]
15. First year renal function as a predictor of kidney allograft outcome.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
[TBL] [Abstract][Full Text] [Related]
16. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
Sagedal S; Hartmann A; Rollag H
Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
[TBL] [Abstract][Full Text] [Related]
17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation, the Halifax experience.
Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
[TBL] [Abstract][Full Text] [Related]
19. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
Helanterä I; Koskinen P; Finne P; Loginov R; Kyllönen L; Salmela K; Grönhagen-Riska C; Lautenschlager I
Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
[TBL] [Abstract][Full Text] [Related]
20. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
